vs
Side-by-side financial comparison of DONALDSON Co INC (DCI) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
DONALDSON Co INC is the larger business by last-quarter revenue ($935.4M vs $493.8M, roughly 1.9× Pediatrix Medical Group, Inc.). DONALDSON Co INC runs the higher net margin — 12.2% vs 6.8%, a 5.4% gap on every dollar of revenue. On growth, DONALDSON Co INC posted the faster year-over-year revenue change (3.9% vs -1.7%). Over the past eight quarters, DONALDSON Co INC's revenue compounded faster (3.3% CAGR vs -0.1%).
Donaldson Company, Inc. is a filtration company engaged in the production and marketing of filtration products used in a variety of industry sectors, including commercial/industrial, aerospace, chemical, alternative energy (windmills), food & beverage, and pharmaceuticals. Also the company's research division, located in Minneapolis, Minn., participated in defense-related projects for various military applications.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DCI vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $935.4M | $493.8M |
| Net Profit | $113.9M | $33.7M |
| Gross Margin | 35.2% | — |
| Operating Margin | 16.0% | 9.9% |
| Net Margin | 12.2% | 6.8% |
| Revenue YoY | 3.9% | -1.7% |
| Net Profit YoY | 15.1% | 10.5% |
| EPS (diluted) | $0.97 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $935.4M | $493.8M | ||
| Q3 25 | $980.7M | $492.9M | ||
| Q2 25 | $940.1M | $468.8M | ||
| Q1 25 | $870.0M | $458.4M | ||
| Q4 24 | $900.1M | $502.4M | ||
| Q3 24 | $935.4M | $511.2M | ||
| Q2 24 | $927.9M | $504.3M | ||
| Q1 24 | $876.7M | $495.1M |
| Q4 25 | $113.9M | $33.7M | ||
| Q3 25 | $114.3M | $71.7M | ||
| Q2 25 | $57.8M | $39.3M | ||
| Q1 25 | $95.9M | $20.7M | ||
| Q4 24 | $99.0M | $30.5M | ||
| Q3 24 | $109.7M | $19.4M | ||
| Q2 24 | $113.5M | $-153.0M | ||
| Q1 24 | $98.7M | $4.0M |
| Q4 25 | 35.2% | — | ||
| Q3 25 | 34.5% | — | ||
| Q2 25 | 34.2% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 35.5% | — | ||
| Q3 24 | 35.8% | — | ||
| Q2 24 | 35.6% | — | ||
| Q1 24 | 35.2% | — |
| Q4 25 | 16.0% | 9.9% | ||
| Q3 25 | 15.5% | 13.8% | ||
| Q2 25 | 9.3% | 12.8% | ||
| Q1 25 | 14.4% | 7.0% | ||
| Q4 24 | 14.5% | 7.8% | ||
| Q3 24 | 15.6% | 6.6% | ||
| Q2 24 | 15.5% | -31.3% | ||
| Q1 24 | 14.8% | 3.2% |
| Q4 25 | 12.2% | 6.8% | ||
| Q3 25 | 11.7% | 14.5% | ||
| Q2 25 | 6.1% | 8.4% | ||
| Q1 25 | 11.0% | 4.5% | ||
| Q4 24 | 11.0% | 6.1% | ||
| Q3 24 | 11.7% | 3.8% | ||
| Q2 24 | 12.2% | -30.3% | ||
| Q1 24 | 11.3% | 0.8% |
| Q4 25 | $0.97 | $0.40 | ||
| Q3 25 | $0.97 | $0.84 | ||
| Q2 25 | $0.48 | $0.46 | ||
| Q1 25 | $0.79 | $0.24 | ||
| Q4 24 | $0.81 | $0.37 | ||
| Q3 24 | $0.90 | $0.23 | ||
| Q2 24 | $0.92 | $-1.84 | ||
| Q1 24 | $0.81 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $210.7M | $375.2M |
| Total DebtLower is stronger | $671.5M | $570.5M |
| Stockholders' EquityBook value | $1.5B | $865.9M |
| Total Assets | $3.0B | $2.2B |
| Debt / EquityLower = less leverage | 0.44× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $210.7M | $375.2M | ||
| Q3 25 | $180.4M | $340.1M | ||
| Q2 25 | $178.5M | $224.7M | ||
| Q1 25 | $189.1M | $99.0M | ||
| Q4 24 | $221.2M | $229.9M | ||
| Q3 24 | $232.7M | $103.8M | ||
| Q2 24 | $223.7M | $19.4M | ||
| Q1 24 | $193.8M | $8.0M |
| Q4 25 | $671.5M | $570.5M | ||
| Q3 25 | $630.4M | $577.2M | ||
| Q2 25 | $638.8M | $583.9M | ||
| Q1 25 | $514.7M | $590.5M | ||
| Q4 24 | $538.6M | $597.1M | ||
| Q3 24 | $483.4M | — | ||
| Q2 24 | $481.8M | — | ||
| Q1 24 | $352.0M | — |
| Q4 25 | $1.5B | $865.9M | ||
| Q3 25 | $1.5B | $890.7M | ||
| Q2 25 | $1.5B | $833.8M | ||
| Q1 25 | $1.5B | $789.2M | ||
| Q4 24 | $1.5B | $764.9M | ||
| Q3 24 | $1.5B | $732.5M | ||
| Q2 24 | $1.5B | $706.5M | ||
| Q1 24 | $1.4B | $856.2M |
| Q4 25 | $3.0B | $2.2B | ||
| Q3 25 | $3.0B | $2.2B | ||
| Q2 25 | $3.0B | $2.1B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.0B | $2.2B | ||
| Q3 24 | $2.9B | $2.1B | ||
| Q2 24 | $2.9B | $2.0B | ||
| Q1 24 | $2.8B | $2.2B |
| Q4 25 | 0.44× | 0.66× | ||
| Q3 25 | 0.43× | 0.65× | ||
| Q2 25 | 0.44× | 0.70× | ||
| Q1 25 | 0.33× | 0.75× | ||
| Q4 24 | 0.35× | 0.78× | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $125.4M | $114.1M |
| Free Cash FlowOCF − Capex | $111.2M | — |
| FCF MarginFCF / Revenue | 11.9% | — |
| Capex IntensityCapex / Revenue | 1.5% | — |
| Cash ConversionOCF / Net Profit | 1.10× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $403.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $125.4M | $114.1M | ||
| Q3 25 | $167.8M | $137.3M | ||
| Q2 25 | $87.7M | $137.2M | ||
| Q1 25 | $90.4M | $-117.5M | ||
| Q4 24 | $72.9M | $133.0M | ||
| Q3 24 | $126.0M | $91.8M | ||
| Q2 24 | $141.5M | $107.0M | ||
| Q1 24 | $87.0M | $-125.2M |
| Q4 25 | $111.2M | — | ||
| Q3 25 | $147.5M | — | ||
| Q2 25 | $73.0M | — | ||
| Q1 25 | $71.5M | — | ||
| Q4 24 | $47.9M | — | ||
| Q3 24 | $106.2M | — | ||
| Q2 24 | $120.2M | — | ||
| Q1 24 | $65.7M | — |
| Q4 25 | 11.9% | — | ||
| Q3 25 | 15.0% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 8.2% | — | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 11.4% | — | ||
| Q2 24 | 13.0% | — | ||
| Q1 24 | 7.5% | — |
| Q4 25 | 1.5% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 2.4% | — |
| Q4 25 | 1.10× | 3.39× | ||
| Q3 25 | 1.47× | 1.91× | ||
| Q2 25 | 1.52× | 3.49× | ||
| Q1 25 | 0.94× | -5.66× | ||
| Q4 24 | 0.74× | 4.36× | ||
| Q3 24 | 1.15× | 4.72× | ||
| Q2 24 | 1.25× | — | ||
| Q1 24 | 0.88× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DCI
| Aftermarket Products | $447.1M | 48% |
| Industrial Filtration Solutions Products | $222.6M | 24% |
| Off Road Products | $86.5M | 9% |
| Life Sciences Segment | $80.0M | 9% |
| Other | $39.1M | 4% |
| Aerospace And Defense Products | $37.1M | 4% |
| On Road Products | $23.0M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
